Geron Corporation
Overview
Geron Corporation is a biotechnology company focused on the development and commercialization of innovative drugs for cancer treatment. The company is a leader in telomerase inhibitors, with its lead drug, imetelstat, undergoing various stages of clinical trials for hematologic malignancies.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Geron Corporation in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.